Is an extended dose of subcutaneous nadroparin anticoagulation equally safe and feasible compared to unfractionated heparin anticoagulation during extracorporeal membrane oxygenation in critically ill COVID-19 patients?

Introduction Unfractionated heparin (UFH) is the traditional anticoagulant of choice in critically ill COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO). Nadroparin, a low molecular weight heparin, potentially offers advantages such as predictable pharmacokinetics and reduced bl...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Paweł Piwowarczyk, Marta Szczukocka, Agata Uchacz, Paweł Kutnik, Tomasz Czarnik, Mirosław Czuczwar, Michał Borys
Format:	Artigo
Jezik:	Inglês
Izdano:	Termedia Publishing House 2025-04-01
Serija:	Anaesthesiology Intensive Therapy
Teme:	respiratory heparin anticoagulation ecmo oxygenation extracorporeal covid-19 nadroparin extended unfractionated
Online dostop:	https://www.ait-journal.com/Is-an-extended-dose-of-subcutaneous-nadroparin-anticoagulation-equally-safe-and-feasible,202605,0,2.html
Oznake:	Označite Brez oznak, prvi označite!